continued

Canara HSBC Life Insurance Declares 271 Crore Bonus for FY2025-26, Marking Continued Value Delivery to Policyholders

Participating policies in force on March 31, 2026 are eligible to receive the bonus amountNEW DELHI, May 22, 2026 /PRNewswire/…

2 weeks ago

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast Track designation, in advanced ovarian…

3 weeks ago

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards

IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical…

2 months ago

Nexteer Celebrates Grand Opening of Thailand Manufacturing Facility & Continued APAC Growth Momentum

AUBURN HILLS, Mich. and RAYONG, Thailand, March 30, 2026 /PRNewswire/ -- Nexteer Automotive celebrated today the grand opening of its…

2 months ago

Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting

Poster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for mTOR-driven skin…

2 months ago

Yutong Bus Reports Continued Sales Growth in 2025, Advancing Sustainable Public Transportation Worldwide

Steady operating performance, innovation-driven growth, and ESG integration reinforce long-term value creationZHENGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Yutong Bus…

4 months ago

Immuron Reports Continued Sales Growth

Sales Highlights (unaudited): Global H1 sales AUD$4.2 million up 5% on prior comparative period (pcp)Q2 sales AUD$2.2 million up 11%…

5 months ago

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued…

5 months ago

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.

January 08, 2026 18:13 ET  | Source: Semilux International Ltd. Taipei, Taiwan, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Semilux International…

5 months ago

Mawson Infrastructure Group Inc. Announces Compliance with Nasdaq Continued Listing Requirements

December 22, 2025 14:05 ET  | Source: Mawson Infrastructure Group Inc. MIDLAND, Pa., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Mawson…

5 months ago